OCA
LLY icon

OpenArc Corporate Advisory’s Eli Lilly LLY Stock Holding History

OpenArc Corporate Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1M Buy
26,730
+1,415
+6% +$1.45M 0.38% 50
2026
Q1 		$23.3M Buy
25,315
+2,366
+10% +$2.4M 0.33% 52
2025
Q4 		$24.7M Buy
+22,949
New +$21.9M 0.41% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OpenArc Corporate Advisory's LLY Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $1.45M and bringing the position to 26,730 shares worth $32.1M. The position accounts for 0.38% of the portfolio, ranked #50.

OpenArc Corporate Advisory first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • OpenArc Corporate Advisory held 26,730 shares of Eli Lilly worth $32.1M as of Q2 2026.
  • OpenArc Corporate Advisory bought 1,415 Eli Lilly shares in Q2 2026, an estimated $1.45M.
  • Eli Lilly made up 0.38% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #50 holding.
  • OpenArc Corporate Advisory first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.